Frontiers in Bioengineering and Biotechnology (May 2022)

FAS2FURIOUS: Moderate-Throughput Secreted Expression of Difficult Recombinant Proteins in Drosophila S2 Cells

  • Jesse A. Coker,
  • Jesse A. Coker,
  • Vittorio L. Katis,
  • Michael Fairhead,
  • Anja Schwenzer,
  • Stine B. Clemmensen,
  • Bent U. Frandsen,
  • Willem A. de Jongh,
  • Opher Gileadi,
  • Nicola A. Burgess-Brown,
  • Brian D. Marsden,
  • Brian D. Marsden,
  • Kim S. Midwood,
  • Wyatt W. Yue

DOI
https://doi.org/10.3389/fbioe.2022.871933
Journal volume & issue
Vol. 10

Abstract

Read online

Recombinant protein expression in eukaryotic insect cells is a powerful approach for producing challenging targets. However, due to incompatibility with standard baculoviral platforms and existing low-throughput methodology, the use of the Drosophila melanogaster “S2” cell line lags behind more common insect cell lines such as Sf9 or High-Five™. Due to the advantages of S2 cells, particularly for secreted and secretable proteins, the lack of a simple and parallelizable S2-based platform represents a bottleneck, particularly for biochemical and biophysical laboratories. Therefore, we developed FAS2FURIOUS, a simple and rapid S2 expression pipeline built upon an existing low-throughput commercial platform. FAS2FURIOUS is comparable in effort to simple E. coli systems and allows users to clone and test up to 46 constructs in just 2 weeks. Given the ability of S2 cells to express challenging targets, including receptor ectodomains, secreted glycoproteins, and viral antigens, FAS2FURIOUS represents an attractive orthogonal approach for protein expression in eukaryotic cells.

Keywords